课题基金 / 基金详情

13th Hershey Developmental Brain Injury Conference

13th Hershey Developmental Brain Injury Conference
第十三届好时发育性脑损伤会议
批准号:
10467344
负责人:
Sandra E Juul
金额:
$2.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-03-01 至 2023-02-28

项目摘要

项目成果

Sandra E Juul的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要/摘要 好时发育性脑损伤会议始于1997年,现已发展到高质量 该计划吸引了包括内科科学家、基础科学家和实习生在内的国际参与者。 会议每隔一年举行一次,地点在国际和美国地点之间轮流举行。 会议包括受邀的演讲者,他们是该领域的杰出人物,以及更初级的 调查人员分享他们的工作。这次会议为学员和年轻人提供了一个绝佳的机会 调查员在轻松的环境中与现场高级调查员会面和互动。科学的 演示文稿总是很出色。桑德拉·朱尔博士组织的2022年第13届好时大会, 伊丽莎白·南斯和托马斯·伍德将被关押在西雅图外的太平洋西北部的华盛顿州 奥尔德布鲁克度假村和水疗中心。我们正在向国立卫生研究院申请资助,主要是为了资助少年儿童的入学。 调查员和实习生。拟议会议的总体目标是召集一个国际集团 专注于新生儿大脑损伤和修复的科学家。今年的主题将是:效果 环境对发育性脑损伤的患病率和结局的影响。这次为期三天的会议 将包括以下会议:发育性脑损伤的长期后果;脑老化和 对二次撞击事件的易感性;表观遗传和微生物组效应;机制和细胞成像 早产/低体重儿的社会、环境和系统影响。会议有四个目标: 1)确定形成基本科学概念的临床范例,并翻译这些新的基本概念 更精细的临床应用 2)探索我们目前知识中的空白领域,并包括切线领域的专家,以提供 对这些差距的新视角 3)促进创新合作 4)促进见习生和初级教员的参与,并从种族/民族中确定见习生/初级教员 少数群体和代表性不足的机构出席这次会议并开展新的合作。在……里面 概述,R13的目标是为学员和初级学员提供必要的持续支持 教职员工将参加第13届好时发育性脑损伤会议。广泛参与 来自美国和国外的学员一直是好时会议的标志。实习生,医学博士 和博士,占所有参与者的30%-40%。这次会议提供了一个极好的机会,非正式 实习生与领域领导者之间的互动以及博士后和博士后培训机制 客座科学家招募。
英文摘要
PROJECT SUMMARY/ABSTRACT The Hershey Conference on Developmental Brain Injury was started in 1997 and has grown to a high-quality program that attracts international attendees that include physician-scientists, basic scientists, and trainees. The conference is held every other year, and the site alternates between international and US locations. Sessions include invited speakers who are luminaries in the field, as well as sessions in which more junior investigators share their work. This conference offers an amazing opportunity for trainees and young investigators to meet and interact with senior investigators in the field in a relaxed environment. The scientific presentations are always outstanding. The 2022 13th Hershey Conference organized by Drs. Sandra Juul, Elizabeth Nance and Thomas Wood will be held in the Pacific Northwest, outside of Seattle Washington at the Alderbrook Resort and Spa. We are applying to NIH for support primarily to fund attendance for junior investigators and trainees. The overall goal of the proposed meeting is to bring together an international group of scientists whose focus is on neonatal brain injury and repair. This year’s overarching theme will be: Effects of the environment on prevalence and outcomes of developmental brain injury. This three-day meeting will include the following sessions: Long-term consequences of developmental brain injury; Brain aging and susceptibility to second hit events; Epigenetic and microbiome effects; Mechanisms and cellular imaging and Societal; environmental, and systemic effects on premature/LBW. The meeting has four objectives: 1) To identify clinical paradigms that inform basic science concepts and translate those new basic concepts into more refined clinical application 2) To explore areas of gaps in our current knowledge, and to include experts in tangential fields to provide new perspectives on these gaps 3) To promote novel collaborations 4) To promote trainee and junior faculty participation and to identify trainees/junior faculty from racial/ethnic minorities and underrepresented institutions to attend this conference and develop new collaborations. In summary, the objective of this R13 is to provide the necessary continued support for trainees and junior faculty to attend the 13th Hershey Conference on Developmental Brain Injury. Extensive participation of trainees, both from US and abroad, has been a hallmark of the Hershey Conference. Trainees, both MD and PhD, constitute 30-40% of all participants. This meeting provides an excellent opportunity for informal interaction between trainees and the leaders in the field as well as a mechanism for post-doctoral and visiting scientist recruitment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Trial of Darbepoetin plus slow-release intravenous iron to decrease transfusions and improve iron status and neurodevelopment in preterm infants
  • 批准号:
    10662182
  • 项目类别:
  • 资助金额:
    $56.38万
  • 财政年份:
    2022
  • 负责人:
    Sandra E Juul
  • 依托单位:
Trial of Darbepoetin plus slow-release intravenous iron to decrease transfusions and improve iron status and neurodevelopment in preterm infants
  • 批准号:
    10340574
  • 项目类别:
  • 资助金额:
    $49.23万
  • 财政年份:
    2022
  • 负责人:
    Sandra E Juul
  • 依托单位:
Intellectual and Developmental Disabilities Research Center
  • 批准号:
    10661668
  • 项目类别:
  • 资助金额:
    $127.18万
  • 财政年份:
    2020
  • 负责人:
    Sandra E Juul
  • 依托单位:
High-dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) CCC
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: